Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma

A better understanding of cancer biology has led to the development of molecular targeted therapy, which has dramatically improved the outcome of some cancer patients, especially when a biomarker of efficacy has been used for patients’ selection. In head and neck oncology, cetuximab that targets epi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gougis, Paul, Moreau Bachelard, Camille, Kamal, Maud, Gan, Hui K, Borcoman, Edith, Torossian, Nouritza, Bièche, Ivan, Le Tourneau, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049986/
https://www.ncbi.nlm.nih.gov/pubmed/32337482
http://dx.doi.org/10.1093/jncics/pkz055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049986/
https://www.ncbi.nlm.nih.gov/pubmed/32337482
http://dx.doi.org/10.1093/jncics/pkz055

Ejemplares similares